Zheng Yan
Company: Novartis AG
Job title: Principle scientist
Seminars:
Preclinical to Clinical Development: Targeting the NLRP3 Inflammasome in Myelodysplastic Syndrome 8:30 am
NLRP3 inflammasome is constitutively active in myelodysplastic syndrome (MDS) Novartis is starting clinical trials to assess the impact of anti-inflammatory molecules in low-risk MDSRead more
day: Conf Day 1